The global polymerase chain reaction market is estimated to be valued at US$ 5,627.9 million in 2022 and is expected to exhibit a CAGR of 8.9% during the forecast period (2022-2030).
Figure 1. Global Polymerase Chain Reaction Market Share (%), by Product Type, 2022
The global polymerase chain reaction market is estimated to be valued at US$ 5,627.9 million in 2022 and is expected to exhibit a CAGR of 8.9% during the forecast period (2022-2030).
Market Trends:
Increasing numbers of product launches in polymerase chain reaction are expected to drive growth of the global polymerase chain reaction market
Key players in the polymerase chain reaction market are engaged in launching advanced and novel PCR instruments and consumables, which will allows rapid and easy nucleic acid amplification. For instance, in October 2017, Diatech Pharmacogenetics S.R.L., a provider of molecular diagnostic tools for precision medicine launched easyPGX: a ready-to-use in-vitro diagnostic real-time PCR product line and Helix: a polymerase chain reaction kit for the extraction of circulating free DNA from plasma. Increasing prevalence of chronic and infectious disease are driving growth of the global polymerase chain reaction market
Polymerase chain reaction is increasingly used in clinical diagnosis of infectious disease, nucleic acid amplification, paternity testing, DNA fingerprinting, detection and diagnosis of infectious disease, quality control, and personalized medicine. For instance, in March 2022, according to data published by Indian Council of Medical Research (ICMR), there will be a 12 percent rise in cancer cases in India by 2027. The most common forms of cancer affecting the people of India are breast cancer, cervical cancer, and oral cancer. Furthermore, in May 2022, according to data published by National Center for Biotechnology Information, projected cancer burden in India for 2021 was 26.7 million and expected to increase to 29.8 million in 2025. In 2021 highest burden was in the north (2408 DALYsAMI per 100,000) and northeastern (2177 DALYsAMI per 100,000) regions of the India and higher among males. More than 40% of the total cancer burden was contributed by the seven leading cancer sites — lung (10.6%), breast (10.5%), oesophagus (5.8%), mouth (5.7%), stomach (5.2%), liver (4.6%), and cervix uteri (4.3%).
Figure 2.Global Polymerase Chain Reaction Market Share (%), by Region, 2022
Polymerase Chain Reaction Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients